World Class Extractions to invest $3 million in Alkaline Spring
By Akshay Kedari  Date: 2019-04-09

World Class Extractions to invest $3 million in Alkaline Spring

World Class has rights to refuse the supply of any hemp or cannabis extracts required in the business of Alkaline Spring.

World Class Extractions Inc. has reportedly announced that it has signed an agreement to invest up to $3 million in Alberta-based Alkaline Spring Inc., a privately-held natural alkaline water company, by way of a private placement. World Class Extractions has invested $2 million in consideration for 11,111,111 common share purchase warrants, 2,000 senior secured convertible debentures of Alkaline Spring, and acquired certain investor rights.

According to the press release by World-Class Extractions, the company would increase its level of engagement with stakeholders, potential institutional and retail investors. It has also engaged investor relations companies to help itself with investor relations and shareholder communications services to communicate its message across a broad range of Canadian investors.

The Alkaline Debentures will be reportedly matured in two years. The debentures have been priced at $1,000 per debenture and bear interest rate at 9 percent per annum. The debentures are convertible into common stake of Alkaline Spring at an initial cost of $0.18 per share, subjected to downward adjustment in certain circumstances.  All the Alkaline Warrants are exercisable into one further share at $0.25 for three years.

World Class has reportedly acquired certain rights to refuse the supply of any hemp or cannabis extracts required in the business of Alkaline Spring. The company can license future formulations of planned cannabis and hemp infused waters of Alkaline Spring and, sell and market its products on white label basis in certain market except Canada. It can also appoint two directors to the board of Alkaline Spring.

Ascension Millionaires Club Inc. and Hybrid Financial Ltd. will assist World Class to enhance market awareness and foster productive dialogues with stakeholders and other market participants.

Hybrid will assist World Class for a term of 6 months in its marketing campaign and will be paid a monthly fee of $15,000. Ascension will help the company with investor relations and communication services for 12 months and will be paid $10,000 monthly.

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

BMW drivers can now unlock and start cars without using their iPhone
BMW drivers can now unlock and start cars without using their iPhone
By Akshay Kedari

German multinational automobile manufacturer, Bayerische Motoren Werke AG, commonly known as BMW, has reportedly unveiled an upgraded version of its mobile car key technology, called the Digital Key Plus. This product enables iPhone users to unlock t...

FMCG firms resort to marginal hike to cope with raw material inflation
FMCG firms resort to marginal hike to cope with raw material inflation
By Akshay Kedari

The recent inflation in raw materials has reportedly prompted players in the FMCG sector to take price hike measures for their products, in a bid to maintain the revenues. According to reliable sources, some FMCG companies, including Marico, have al...

boAt raises USD 100 million in funding from Warburg Pincus
boAt raises USD 100 million in funding from Warburg Pincus
By Akshay Kedari

Indian consumer electronics brand, boAt, has reportedly secured funding of USD 100 million from Warburg Pincus, a New-York-based private equity firm, at a USD 300 million valuation. The company will utilize these funds to expand its product portfoli...

Elevar Therapeutics and Inceptua partner to commercialize Apealea®
Elevar Therapeutics and Inceptua partner to commercialize Apealea®
By Akshay Kedari

According to reliable sources, U.S.-based fully integrated biopharmaceutical company, Elevar Therapeutics Inc., has signed an exclusive agreement with Inceptua Group for the commercialization and distribution of its non-cremophor based paclitaxel tre...

NASA completes construction of ‘LC-48’ at Kennedy Space Center
NASA completes construction of ‘LC-48’ at Kennedy Space Center
By Akshay Kedari

The National Aeronautics and Space Administration (NASA) has reportedly announced the completion of the construction of its new launchpad at the Kennedy Space Center based in Florida. Notably, the new Launch Complex 48 or LC-48 is a pad that will be ...